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Background
Recent studies have suggested that HIV-1 can evade
Natural Killer (NK)-cell-mediated immunity by mutating
viral epitopes to enhance engagement of inhibitory Killer
Ig-like receptors (KIRs) expressed on NK cells. However,
the precise mechanisms modulating the interaction of
inhibitory KIRs and their HLA class I ligands, and the
role that HIV-1 epitopes might play in this interaction
are not well understood. In this study we investigated
whether HLA-Cw3-presented epitopes within HIV-1
p24 Gag can modulate binding of KIR2DL2, an inhibi-
tory KIR, to HLA-Cw03.
Methods
Using tapasin-deficient 721.220 cell line expressing
HLA-Cw*0304 we initially screened for HIV-1 peptides
that stabilized HLA-Cw*0304 expression using 222 10-
mer peptides overlapping by 9 amino acids spanning the
entire HIV-1 p24 Gag sequence. Peptides stabalizing
HLA-Cw*0304 expression were thereafter investigated
for their ability to facilitate binding of a KIR2DL2-IgG
fusion construct.
Results
We identified several HIV-1 p24 epitopes that were able
to stabilize HLA–Cw*0304 expression. A subset of these
epitopes also allowed for binding of KIR2DL2. Currently
we are investigating the consequences of KIR2DL2-bind-
ing to HLA class I presented HIV-1 epitopes for the
antiviral function of primary NK cells from KIR2DL2+
individuals.
Conclusion
Taken together, these studies have identified epitopes
within HIV-1 that enhance the binding of the inhibitory
NK cell receptor KIR2DL2 to its ligand HLA-Cw3, and
are in line with recent data suggesting that the sequence
of the HLA class I presented epitope has an important
impact on the interaction between KIR and HLA class I
(Boyington et al. Nature 2000, Vivian et al. Nature
2011).
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